Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab in Crohn's Disease
NCT02321280Phase 2Completed
- Sponsor
- University of Manitoba
- Start
- Feb 2015
- Primary completion
- Apr 2018
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of denosumab in Crohn's disease, sponsored by University of Manitoba. Started Feb 2015; status: completed.
02
Drugs
denosumab
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT02321280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02321280.